Skip to main content
. 2019 Oct 30;9:15641. doi: 10.1038/s41598-019-52253-y

Figure 1.

Figure 1

BBR increases Trib1 mRNA levels and reduces circulating serum lipid levels in hyperlipidemic mice. Mice fed a HFHCD diet were treated with BBR (200 mg/kg, n = 10) or with vehicle (n = 10) for 14 days. At the end of drug treatment all the mice were sacrificed for serum and liver tissue collection. (AC) LDL-C, TC and TG levels in mice sera were measured after the treatment with BBR or the vehicle. (D) Liver index was measured in BBR or the vehicle treated mice. (EF) Liver TG and TC contents were measured in individual liver sample treated with BBR or the vehicle. (G) Quantitative real-time PCR were used to determine the relative expression levels of Trib1 and other hepatic genes after normalization with Gapdh mRNA levels. Values are the mean ± S.E.M. of 10 samples per group. *P < 0.05, **P < 0.01, and ***P < 0.001, compared with the vehicle control group.